Ulusal Romatoloji Dergisi / Journal of Turkish Society for Rheumatology
p-ISSN: 2651-2653
e-ISSN: 2651-2661
Haner Direskeneli
2019 Volume 11
Deomed Yayıncılık
Volume 9, Issue 1-2, December 2017
Page(s): 1-5
Clinical Research Article
Received: March 23, 2017; Accepted: August 22, 2017; Published online: November 1, 2017
doi:10.2399/raed.17.21939; Copyright © 2017 Turkish Society for Rheumatology
Difficulties on follow-up of rheumatologic diseases in geriatric patients
Neslihan Yılmaz1 (E-mail), Banu Özulu Türkmen2, Mehtap Üçer3, Aslı Çurgunlu2, Şule Yavuz1
1Division of Rheumatology, Faculty of Medicine, Istanbul Bilim University, Istanbul, Turkey; 2Division of Geriatrics, Faculty of Medicine, Istanbul Bilim University, Istanbul, Turkey; 3Department of Internal Medicine, Faculty of Medicine, Istanbul Bilim University, Istanbul, Turkey
Objective: Musculoskeletal disorders are one of the most common problems in elderly and also an important cause of morbidity. The aim of our study is define characteristics of rheumatic problems in the elderly.

Methods: In this study, patients with a diagnosis of rheumatologic diseases over 65 years of age and followed between 2013 and 2017 were retrospectively evaluated.

Results: A total of 148 patients (female: 105, male: 43) were included to our study. The mean age was 75.3±6.5 years. Rheumatoid arthritis was identified as the most frequent rheumatologic disease in this group. All patients had at least one concommittant disease and the most common were hypertension and osteoporosis. Patients has long-term follow-up were evaluated seperately for drug side effects. In this subgroup; almost all patients were using corticosteroids (87/90, 96.6%) and synthetic disease modifying drugs (DMARDs) (85/90, 94.4%) and, a small number of patients (9/90, 10%) were treated with biological drugs. We observed severe infection in 3, hyperglisemia in 7 and myopathy in 1 patients due to steroids. Severe gastrointestinal bleeding was observed in 1 patient using non-steroidal antiinflammatory drug (NSAID). Only mild side effects, recovering after reducing the dose or changing the drug, were determined due to synthetic DMARDs.

Conclusion: Rheumatoid arthritis was found to be the most common elderly onset inflammatory rheumatologic disease. Choosing the appropriate treatment option can be difficult due to comorbidities in geriatric patients. The most significant side effects were observed in high dose corticosteroid and NSAIDs usage. However, in study group synthetic DMARDs were generally well tolerated.
Keywords: Geriatric period, late onset, rheumatic diseases
RAED Dergisi / RAED Journal

Türkiye Romatoloji Derneği (TRD) yayın organıdır. Deomed Yayıncılık tarafından yayımlanmaktadır. / Official Publication of the Rheumatology Society of Turkey (TRD). Published by Deomed Publishing. Copyright © 2019, TRD.
Creative Commons License
RAED Dergisi çevrimiçi (online) sürümünde yayımlanan akademik içeriğin kullanım hakları, ilgili içerikte tersi belirtilmediği sürece Deomed Yayıncılık tarafından Creative Commons Attribution-NoCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND3.0) lisansı aracılığıyla bedelsiz sunulmaktadır. / Except where otherwise noted, academic content of this online version of the journal by Deomed Publishing is licensed under the terms of Creative Commons Attribution-NoCommercial-NoDerivs 3.0 Unported (CC BY-NC-ND3.0) License.